As one of the most abundant and important drug-metabolizing enzymes, the expression of CYP2C9 is associated with the risk of several diseases, such as lung cancer [37], colorectal cancer [38], and colorectal adenoma [39]. Here, CYP2C9 is linked to colorectal adenoma.